Get access
  • News
Powerful Medical
•
3. August 2023

Dr. Fakhar Khan, Distinguished Consultant Cardiologist, Joins UK Clinical Board for PMcardio

  • News

We are thrilled to announce the latest addition to our UK Clinical Board, Dr. Fakhar Khan, an award-winning Consultant Cardiologist with a profound understanding of the unique demands of the UK’s healthcare landscape.

Currently serving at St Bartholomew’s Hospital’s Barts Heart Centre and the Royal Free Hospital in Hamstead, Dr. Khan brings unparalleled expertise in managing heart rhythm disorders. His deep understanding of the healthcare system in the UK, strengthened by his extensive training at Oxford, Papworth Hospital, and Addenbrooke’s Hospital, coupled with his experience at prestigious healthcare centres, equips him with unique insights that will immensely benefit our board’s decision-making process.

An acclaimed medical researcher, Dr. Khan has made remarkable strides in improving patient outcomes, including leading a major clinical trial at Cambridge University. His numerous peer-reviewed articles and insightful speeches at international conferences in the US and Europe underscore his dedication to advancing healthcare.

Recognised by the Heart Rhythm Society UK with the Young Investigator Award in 2010 and the prestigious Ralph Noble Prize from the University of Cambridge, Dr. Khan’s work truly stands out in the field of clinical medicine.

With his blend of clinical expertise, research prowess, and an intrinsic understanding of the UK healthcare system, we are confident that Dr. Khan will be an invaluable asset to our UK Clinical Board. We eagerly anticipate the innovative insights and guidance he will bring to our team.

Dr. Fakhar Khan, Distinguished Consultant Cardiologist, Joins UK Clinical Board for PMcardio
Dr. Fakhar Khan, Distinguished Consultant Cardiologist, Joins UK Clinical Board for PMcardio

Stay on the pulse with our newsletter

Your submission was successful

About Dr. Fakhar Khan Dr. Fakhar Khan is a Consultant Cardiologist specializing in heart rhythm disorders, currently serving at the Barts Heart Centre and the Royal Free Hospital. With his medical degree from the University of Cambridge and additional training across renowned institutions, he brings a unique blend of clinical expertise and research acumen. As an esteemed researcher and recipient of significant awards such as the Young Investigator Award and the Ralph Noble Prize, Dr. Khan’s contributions significantly impact the landscape of clinical medicine.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

Share this article

Don't miss these

More articles
Left Ventricular Systolic Dysfunction (LVSD) (2)
  • AI, Education, Research

Left Ventricular Systolic Dysfunction: The Basics and AI Advancements in Detection

In this comprehensive article, we delve into the intricacies of Left Ventricular Systolic Dysfunction (LVSD), thoroughly analyzing its symptoms, causes, and severity. We explore the latest advancements in diagnostic tools and real-world case studies.
  • AI, Case Studies, Heartfelt Impact, OMI

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.
More articles

Join 25,000 healthcare professionals who are already taking advantage of AI

Register now

Ready to get started?

Get access

Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.

Products

Company

Resources

Legal

Envelope Linkedin-in Instagram Facebook-f

© Powerful Medical 2024

Privacy

&

Cookies

Legal

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.

Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Sign up